InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Richard A Graham, a SVP, RESEARCH & DEVELOPMENT, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 13 open-market SEC Form 4 transactions: 0 purchases worth $0 and 13 sales worth $447K, reported from Aug 9, 22 to Nov 14, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 14, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.5K | $10.22 | $25K |
| Oct 16, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.5K | $9.03 | $22K |
| Sep 14, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.5K | $9.89 | $25K |
| Aug 11, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $9.99 | $23K |
| Jul 14, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $9.84 | $23K |
| Jun 14, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $10.69 | $25K |
| May 15, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $11.26 | $26K |
| Apr 14, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $11.88 | $28K |
| Mar 14, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $10.32 | $24K |
| Mar 6, 23 | TBPHTheravance Biopharma, Inc. | SELL | 2.3K | $10.05 | $23K |
| Dec 1, 22 | TBPHTheravance Biopharma, Inc. | SELL | 2.1K | $10.73 | $22K |
| Aug 16, 22 | TBPHTheravance Biopharma, Inc. | SELL | 4.9K | $9.71 | $48K |
| Aug 9, 22 | TBPHTheravance Biopharma, Inc. | SELL | 15.1K | $8.79 | $133K |